Pilot program to provide cheaper GLP-1 via Medicare stokes shortage fears

A new pilot program under Medicare is offering the popular GLP-1 drug at a significantly reduced price of $50 for eligible seniors, sparking concerns about potential shortages. Retiree Kathryn, who has struggled with weight issues, is among those hoping the program will help her manage her health. While the initiative aims to make the treatment more accessible, experts worry that the increased demand could exacerbate existing supply issues, potentially limiting availability for those who need it most. This move underscores the ongoing challenges in balancing cost and access in healthcare.